Accelerated wound closure of pressure ulcers in aged mice by chitosan scaffolds with and without bFGF

Chan J. Park, Sherrie G. Clark, Carol A. Lichtensteiger, Russell D. Jamison, Amy J Wagoner Johnson

Research output: Contribution to journalArticle

Abstract

Pressure ulcers are a significant healthcare concern, especially for elderly populations. Our work served to ameliorate the chronicity of these ulcers by addressing ischemia-reperfusion injury mediated by neutrophils and the concomitant loss of vasculature in these wounds. To this end, chitosan scaffolds loaded with basic fibroblast growth factor (bFGF) contained in gelatin microparticles were developed and tested for clinical relevance in an aged mouse model. Pressure ulcers were induced in aged mice, and efficacy of treatment was assessed. On days 3 and 7, both chitosan and chitosan-bFGF scaffolds significantly accelerated wound closure compared to gauze control. By day 10, all wounds achieved similar closure. Delivery and angiogenic function of bFGF was verified through ELISA and histology. Elevated neutrophil levels were observed in chitosan and chitosan-bFGF groups. Since neutrophil elastase contributes to the proteolytic environments of pressure ulcers, the effect of chitosan on elastase was assessed. In vitro, chitosan inhibited elastase activity. In vivo, elastase protein levels in wounds were reduced with chitosan-bFGF scaffolds by day 10. These results suggest that chitosan is an effective material for growth factor delivery and can help to heal chronic ulcers. Collectively, our data show that chitosan-bFGF scaffolds are effective in accelerating wound closure of pressure ulcers in aged animals.

Original languageEnglish (US)
Pages (from-to)1926-1936
Number of pages11
JournalActa Biomaterialia
Volume5
Issue number6
DOIs
StatePublished - Jul 1 2009

Fingerprint

Pressure Ulcer
Chitosan
Fibroblast Growth Factor 2
Fibroblasts
Scaffolds
Wounds and Injuries
Pancreatic Elastase
Ulcer
Neutrophils
Intercellular Signaling Peptides and Proteins
Leukocyte Elastase
Histology
Gelatin
Reperfusion Injury
Animals
Enzyme-Linked Immunosorbent Assay
Proteins
Delivery of Health Care

Keywords

  • bFGF
  • Chitosan
  • Pressure ulcers
  • Wound healing

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering
  • Biotechnology
  • Biochemistry
  • Molecular Biology

Cite this

Accelerated wound closure of pressure ulcers in aged mice by chitosan scaffolds with and without bFGF. / Park, Chan J.; Clark, Sherrie G.; Lichtensteiger, Carol A.; Jamison, Russell D.; Johnson, Amy J Wagoner.

In: Acta Biomaterialia, Vol. 5, No. 6, 01.07.2009, p. 1926-1936.

Research output: Contribution to journalArticle

Park, Chan J. ; Clark, Sherrie G. ; Lichtensteiger, Carol A. ; Jamison, Russell D. ; Johnson, Amy J Wagoner. / Accelerated wound closure of pressure ulcers in aged mice by chitosan scaffolds with and without bFGF. In: Acta Biomaterialia. 2009 ; Vol. 5, No. 6. pp. 1926-1936.
@article{e821d791537f488cb18e9316181581d5,
title = "Accelerated wound closure of pressure ulcers in aged mice by chitosan scaffolds with and without bFGF",
abstract = "Pressure ulcers are a significant healthcare concern, especially for elderly populations. Our work served to ameliorate the chronicity of these ulcers by addressing ischemia-reperfusion injury mediated by neutrophils and the concomitant loss of vasculature in these wounds. To this end, chitosan scaffolds loaded with basic fibroblast growth factor (bFGF) contained in gelatin microparticles were developed and tested for clinical relevance in an aged mouse model. Pressure ulcers were induced in aged mice, and efficacy of treatment was assessed. On days 3 and 7, both chitosan and chitosan-bFGF scaffolds significantly accelerated wound closure compared to gauze control. By day 10, all wounds achieved similar closure. Delivery and angiogenic function of bFGF was verified through ELISA and histology. Elevated neutrophil levels were observed in chitosan and chitosan-bFGF groups. Since neutrophil elastase contributes to the proteolytic environments of pressure ulcers, the effect of chitosan on elastase was assessed. In vitro, chitosan inhibited elastase activity. In vivo, elastase protein levels in wounds were reduced with chitosan-bFGF scaffolds by day 10. These results suggest that chitosan is an effective material for growth factor delivery and can help to heal chronic ulcers. Collectively, our data show that chitosan-bFGF scaffolds are effective in accelerating wound closure of pressure ulcers in aged animals.",
keywords = "bFGF, Chitosan, Pressure ulcers, Wound healing",
author = "Park, {Chan J.} and Clark, {Sherrie G.} and Lichtensteiger, {Carol A.} and Jamison, {Russell D.} and Johnson, {Amy J Wagoner}",
year = "2009",
month = "7",
day = "1",
doi = "10.1016/j.actbio.2009.03.002",
language = "English (US)",
volume = "5",
pages = "1926--1936",
journal = "Acta Biomaterialia",
issn = "1742-7061",
publisher = "Elsevier BV",
number = "6",

}

TY - JOUR

T1 - Accelerated wound closure of pressure ulcers in aged mice by chitosan scaffolds with and without bFGF

AU - Park, Chan J.

AU - Clark, Sherrie G.

AU - Lichtensteiger, Carol A.

AU - Jamison, Russell D.

AU - Johnson, Amy J Wagoner

PY - 2009/7/1

Y1 - 2009/7/1

N2 - Pressure ulcers are a significant healthcare concern, especially for elderly populations. Our work served to ameliorate the chronicity of these ulcers by addressing ischemia-reperfusion injury mediated by neutrophils and the concomitant loss of vasculature in these wounds. To this end, chitosan scaffolds loaded with basic fibroblast growth factor (bFGF) contained in gelatin microparticles were developed and tested for clinical relevance in an aged mouse model. Pressure ulcers were induced in aged mice, and efficacy of treatment was assessed. On days 3 and 7, both chitosan and chitosan-bFGF scaffolds significantly accelerated wound closure compared to gauze control. By day 10, all wounds achieved similar closure. Delivery and angiogenic function of bFGF was verified through ELISA and histology. Elevated neutrophil levels were observed in chitosan and chitosan-bFGF groups. Since neutrophil elastase contributes to the proteolytic environments of pressure ulcers, the effect of chitosan on elastase was assessed. In vitro, chitosan inhibited elastase activity. In vivo, elastase protein levels in wounds were reduced with chitosan-bFGF scaffolds by day 10. These results suggest that chitosan is an effective material for growth factor delivery and can help to heal chronic ulcers. Collectively, our data show that chitosan-bFGF scaffolds are effective in accelerating wound closure of pressure ulcers in aged animals.

AB - Pressure ulcers are a significant healthcare concern, especially for elderly populations. Our work served to ameliorate the chronicity of these ulcers by addressing ischemia-reperfusion injury mediated by neutrophils and the concomitant loss of vasculature in these wounds. To this end, chitosan scaffolds loaded with basic fibroblast growth factor (bFGF) contained in gelatin microparticles were developed and tested for clinical relevance in an aged mouse model. Pressure ulcers were induced in aged mice, and efficacy of treatment was assessed. On days 3 and 7, both chitosan and chitosan-bFGF scaffolds significantly accelerated wound closure compared to gauze control. By day 10, all wounds achieved similar closure. Delivery and angiogenic function of bFGF was verified through ELISA and histology. Elevated neutrophil levels were observed in chitosan and chitosan-bFGF groups. Since neutrophil elastase contributes to the proteolytic environments of pressure ulcers, the effect of chitosan on elastase was assessed. In vitro, chitosan inhibited elastase activity. In vivo, elastase protein levels in wounds were reduced with chitosan-bFGF scaffolds by day 10. These results suggest that chitosan is an effective material for growth factor delivery and can help to heal chronic ulcers. Collectively, our data show that chitosan-bFGF scaffolds are effective in accelerating wound closure of pressure ulcers in aged animals.

KW - bFGF

KW - Chitosan

KW - Pressure ulcers

KW - Wound healing

UR - http://www.scopus.com/inward/record.url?scp=67349238742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349238742&partnerID=8YFLogxK

U2 - 10.1016/j.actbio.2009.03.002

DO - 10.1016/j.actbio.2009.03.002

M3 - Article

C2 - 19342320

AN - SCOPUS:67349238742

VL - 5

SP - 1926

EP - 1936

JO - Acta Biomaterialia

JF - Acta Biomaterialia

SN - 1742-7061

IS - 6

ER -